918 results on '"Ponzoni, M."'
Search Results
2. EAHP 2020 workshop proceedings, pediatric myeloid neoplasms
3. Lymphadenitis/Reactive-Hyperplasia, Mimickers of Lymphomas, Low-Grade B-Cell Lymphomas, and Hodgkin Lymphoma.
4. The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation
5. A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.)
6. Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas
7. A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects
8. Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma
9. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma
10. sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib
11. Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma
12. Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium
13. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak
14. The aetiology of B‐cell lymphoid malignancies with a focus on chronic inflammation and infections
15. A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation
16. Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
17. Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit
18. Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
19. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
20. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications
21. Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity
22. Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation
23. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy
24. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin’s lymphoma
25. NY-ESO-1-SPECIFIC SINGLE EDITED T CELLS ENSURE TUMOR REJECTION WITHOUT INDUCING XENOGENEIC GVHD: PH-O096
26. OFF-TUMOR TARGET EXPRESSION LEVELS DO NOT PREDICT CAR-T CELL KILLING: A FOUNDATION FOR THE SAFETY OF CD44V6-TARGETED T CELLS: PH-O031
27. NON-LINEAR CLONAL EVOLUTION OF LEUKEMIA DRIVEN BY THE SELECTIVE IMMUNE PRESSURE OF ALLOGENEIC HSCT: PH-O014
28. Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.) (Virchows Archiv, (2019), 475, 4, (513-518), 10.1007/s00428-019-02637-2)
29. Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)
30. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients
31. Dual regulation of Myc by Abl
32. Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma
33. Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma
34. Intravascular Lymphomatosis (IL) in a Child Mimicking a Posterior Fossa Tumor
35. Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa
36. Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire
37. Prevalence of chlamydial infection in a series of 108 primary cutaneous lymphomas
38. Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion
39. Prep1 (pKnox1)-deficiency leads to spontaneous tumor development in mice and accelerates EμMyc lymphomagenesis: A tumor suppressor role for Prep1
40. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma#
41. Successful pregnancy after chemo-immuno-radiation therapy for aggressive lymphoma of the uterus
42. TK007 phase II study final analysis. Genetically modified donor lymphocytes abate transplant related mortality and increase leukaemia-free survival providing early immune reconstitution after haploidentical haematopoietic stem cell transplantation
43. Targeting of a therapeutic suicide gene to human alloreactive memory T-cells with stem-cell features requires IL-7 and IL-15
44. Chlamydia psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma
45. Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations
46. Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas
47. Hepatitis C virus infection and MALT-type ocular adnexal lymphoma
48. Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial
49. Rapamycin Induces a Caspase-Independent Cell Death in Human Monocytes
50. The prevalence and clinical implications of c-kit expression in plasma cell myeloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.